Guidelinevery high evidence

2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA).

European heart journal·August 28, 2026·PMID 42661426

Why it matters

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease, yet management is often suboptimal due to fragmented care. These joint guidelines offer a unified, evidence-based framework to improve cardiovascular and renal outcomes in this high-risk population.

Infographic summary of 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease, in collaboration with the European Renal Association (ERA).
Visual abstract · MedLit

The papers that matter, first.

MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.

§

MedLit · Evidence, Distilled